表紙:末梢血管デバイスの世界市場:市場規模、動向および分析(2024年~2030年):MedSuite
市場調査レポート
商品コード
1378368

末梢血管デバイスの世界市場:市場規模、動向および分析(2024年~2030年):MedSuite

Peripheral Vascular Devices Market Size, Share & Trends Analysis | Global | 2024-2030 | MedSuite | Includes: Drug-Coated Balloons, Atherectomy Devices, Peripheral Vascular Shunts, and 14 more

出版日: | 発行: iData Research Inc. | ページ情報: 英文 1300 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.08円
末梢血管デバイスの世界市場:市場規模、動向および分析(2024年~2030年):MedSuite
出版日: 2023年11月06日
発行: iData Research Inc.
ページ情報: 英文 1300 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の末梢血管デバイスの市場規模は、2023年に129億ドルの評価額を達成し、予測期間中にはCAGR 4.4%で成長し、174億ドル以上に達すると見込まれています。

当レポートでは、世界の末梢血管デバイス市場について調査し、市場の概要とともに、セグメント別動向、COVID-19の影響分析、市場促進要因および阻害要因、競合市場シェア分析、および市場に参入する企業のプロファイルなどを提供しています。

目次

エグゼクティブサマリー

調査手法

COVID-19が世界の末梢血管デバイス市場に与える影響

病気の概要

  • 基本的な解剖学
  • 病気の治療と診断
    • 大動脈瘤
    • アテローム性動脈硬化症
    • 末梢動脈疾患(PAD)
    • 深部静脈血栓症
    • 肺塞栓症
  • 患者の人口統計

製品の評価

  • イントロダクション
  • 製品ポートフォリオ
  • 規制上の問題とリコール
  • 臨床試験

世界の末梢血管装置市場概要

  • イントロダクション
  • 市場概要とトレンド分析
  • 促進要因と抑制要因
  • 競合市場シェア分析
  • 合併と買収
  • 企業プロファイル
    • Abbott
    • Becton Dickinson
    • Boston Scientific
    • Cardinal Health
    • Cardiovascular Systems, Inc.
    • Cook Medical
    • Medtronic
    • Penumbra
    • Philips
    • Shockwave Medical
    • Silk Road Medical
    • Terumo
    • W.L. Gore
  • SWOT分析

末梢血管ステント市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

経皮経腔血管形成術バルーン市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

薬剤コーティングバルーン市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

アテレクトミーデバイス市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

血管内結石破砕術市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

慢性完全閉塞デバイス市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

外科用移植片市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

ステントグラフト市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

塞栓予防装置市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

末梢血栓管理市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

下大静脈フィルター市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

頸動脈シャント市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

診断用およびインターベンションカテーテル市場

  • エグゼクティブサマリー
  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

診断およびインターベンションガイドワイヤ市場

  • エグゼクティブサマリー
  • イントロダクション
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

イントロデューサーシース市場

  • エグゼクティブサマリー
    • 世界のイントロデューサーシース市場概要
    • 競合分析
    • 含まれる地域
  • イントロダクション
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

血管閉鎖デバイス市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

経カテーテル塞栓市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場概要
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

末梢血管内超音波市場

  • エグゼクティブサマリー
  • イントロダクション
  • 手技件数
  • 市場分析と予測
  • 促進要因と抑制要因
  • 競合市場シェア分析

略語

図表

LIST OF CHARTS

  • Chart 1-1: Peripheral Vascular Device Market by Segment, Global, 2023 - 2030
  • Chart 1-2: Peripheral Vascular Device Procedures, Global, 2023
  • Chart 2-1: Multi-Scenario Peripheral Vascular Device Market Forecast, Global, 2020 - 2030 (US$M)
  • Chart 5-1: Peripheral Vascular Device Market by Segment, Global, 2020 - 2030
  • Chart 5-2: Peripheral Vascular Device Market by Region, Global, 2020 - 2030
  • Chart 5-3: Leading Competitors, Peripheral Vascular Device Market, Global, 2023
  • Chart 6-1: Peripheral Vascular Stent Market, Global, 2023 & 2030
  • Chart 6-2: Peripheral Vascular Stent Procedures, Global, 2023
  • Chart 6-3: Peripheral Vascular Stenting Procedures by Region, Global, 2020 - 2030
  • Chart 6-4: Peripheral Vascular Stent Market by Segment, Global, 2020 - 2030
  • Chart 6-5: Peripheral Vascular Stent Market by Region, Global, 2020 - 2030
  • Chart 6-6: Leading Competitors, Peripheral Vascular Stent Market, Global, 2023
  • Chart 7-1: Percutaneous Transluminal Angioplasty Balloon Market, Global, 2023 & 2030
  • Chart 7-2: Percutaneous Transluminal Angioplasty Balloon Procedures, Global, 2023
  • Chart 7-3: PTA Balloon Procedures by Region, Global, 2020 - 2030
  • Chart 7-4: PTA Balloon Market by Segment, Global, 2020 - 2030
  • Chart 7-5: PTA Balloon Market by Region, Global, 2020 - 2030
  • Chart 7-6: Leading Competitors, Percutaneous Transluminal Angioplasty Balloon Market, Global, 2023
  • Chart 8-1: Drug-Coated Balloon Market, Global, 2023 & 2030
  • Chart 8-2: Drug-Coated Balloon Procedures, Global, 2023
  • Chart 8-3: Drug-Coated Balloon Procedures by Region, Global, 2020 - 2030
  • Chart 8-4: Drug-Coated Balloon Market, Global, 2020 - 2030
  • Chart 8-5: Leading Competitors, Drug-Coated Balloon Market, Global, 2023
  • Chart 9-1: Atherectomy Device Market, Global, 2023 & 2030
  • Chart 9-2: Atherectomy Procedures, Global, 2023
  • Chart 9-3: Atherectomy Procedures by Region, Global, 2020 - 2030
  • Chart 9-4: Atherectomy Device Market by Segment, Global, 2020 - 2030
  • Chart 9-5: Atherectomy Device Market by Region, Global, 2020 - 2030
  • Chart 9-6: Leading Competitors, Atherectomy Device Market, Global, 2023
  • Chart 10-1: Intravascular Lithotripsy Market, Global, 2023 & 2030
  • Chart 10-2: Intravascular Lithotripsy Procedures, Global, 2023
  • Chart 10-3: Intravascular Lithotripsy Procedures by Region, Global, 2020 - 2030
  • Chart 10-4: Intravascular Lithotripsy Market, Global, 2020 - 2030
  • Chart 11-1: CTO Device Market, Global, 2023 & 2030
  • Chart 11-2: CTO Procedures, Global, 2023
  • Chart 11-3: CTO Procedures by Region, Global, 2020 - 2030
  • Chart 11-4: CTO Device Market by Segment, Global, 2020 - 2030
  • Chart 11-5: CTO Device Market by Region, Global, 2020 - 2030
  • Chart 11-6: Leading Competitors, CTO Device Market, Global, 2023
  • Chart 12-1: Surgical Graft Market, Global, 2023 & 2030
  • Chart 12-2: Surgical Graft Procedures, Global, 2023
  • Chart 12-3: Surgical Graft Procedures by Region, Global, 2020 - 2030
  • Chart 12-4: Surgical Graft Market by Segment, Global, 2020 - 2030
  • Chart 12-5: Surgical Graft Market by Region, Global, 2020 - 2030
  • Chart 12-6: Leading Competitors, Surgical Graft Market, Global, 2023
  • Chart 13-1: Stent Graft Market, Global, 2023 & 2030
  • Chart 13-2: Stent Graft Procedures, Global, 2023
  • Chart 13-3: Stent Graft Procedures by Segment, Global, 2020 - 2030
  • Chart 13-4: Stent Graft Market by Segment, Global, 2020 - 2030
  • Chart 13-5: Stent Graft Market by Region, Global, 2020 - 2030
  • Chart 13-6: Leading Competitors, Stent Graft Market, Global, 2023
  • Chart 14-1: Embolic Protection Device Market, Global, 2023 & 2030
  • Chart 14-2: Embolic Protection Device Procedures, Global, 2023
  • Chart 14-3: Embolic Protection Device Procedures by Region, Global, 2020 - 2030
  • Chart 14-4: Embolic Protection Device Market by Segment, Global, 2020 - 2030
  • Chart 14-5: Embolic Protection Device Market by Region, Global, 2020 - 2030
  • Chart 14-6: Leading Competitors, Embolic Protection Device Market, Global, 2023
  • Chart 15-1: Peripheral Thrombus Management Market, Global, 2023 & 2030
  • Chart 15-2: Peripheral Thrombus Management Procedures, Global, 2023
  • Chart 15-3: Peripheral Thrombus Management Procedures by Region, Global, 2020 - 2030
  • Chart 15-4: Peripheral Thrombus Management Market by Segment, Global, 2020 - 2030
  • Chart 15-5: Peripheral Thrombus Management Market by Region, Global, 2020 - 2030
  • Chart 15-6: Leading Competitors, Peripheral Thrombus Management Market, Global, 2023
  • Chart 16-1: Inferior Vena Cava Filter Market, Global, 2023 & 2030
  • Chart 16-2: Inferior Vena Cava Filter Placement Procedures, Global, 2023
  • Chart 16-3: Inferior Vena Cava Filter Placement Procedures by Region, Global, 2020 - 2030
  • Chart 16-4: Inferior Vena Cava Filter Market, Global, 2020 - 2030
  • Chart 16-5: Leading Competitors, Inferior Vena Cava Filter Market, Global, 2023
  • Chart 17-1: Carotid Shunt Market, Global, 2023 & 2030
  • Chart 17-2: Carotid Endarterectomy Procedures, Global, 2023
  • Chart 17-3: Carotid Endarterectomy Procedures by Region, Global, 2020 - 2030
  • Chart 17-4: Carotid Shunt Market, Global, 2020 - 2030
  • Chart 17-5: Leading Competitors, Carotid Shunt Market, Global, 2023
  • Chart 18-1: Diagnostic & Interventional Catheter Market, Global, 2023 & 2030
  • Chart 18-2: Diagnostic & Interventional Catheter Units Sold, Global, 2023
  • Chart 18-3: Diagnostic & Interventional Catheter Market by Segment, Global, 2020 - 2030
  • Chart 18-4: Diagnostic & Interventional Catheter Market by Region, Global, 2020 - 2030
  • Chart 18-5: Leading Competitors, Diagnostic & Interventional Catheter Market, Global, 2023
  • Chart 19-1: Diagnostic & Interventional Guidewire Market, Global, 2023 & 2030
  • Chart 19-2: Diagnostic & Interventional Guidewire Units Sold, Global, 2023
  • Chart 19-3: Diagnostic and Interventional Guidewire Market by Segment, Global, 2020 - 2030
  • Chart 19-4: Diagnostic & Interventional Guidewire Market by Region, Global, 2020 - 2030
  • Chart 19-5: Leading Competitors, Diagnostic & Interventional Guidewire Market, Global, 2023
  • Chart 20-1: Introducer Sheath Market, Global, 2023 & 2030
  • Chart 20-2: Introducer Sheath Units Sold, Global, 2023
  • Chart 20-3: Introducer Sheath Market, Global, 2020 - 2030
  • Chart 20-4: Leading Competitors, Introducer Sheath Market, Global, 2023
  • Chart 21-1: Vascular Closure Device Market, Global, 2023 & 2030
  • Chart 21-2: Vascular Closure Device Procedures, Global, 2023
  • Chart 21-3: Vascular Closure Device Procedures by Region, Global, 2020 - 2030
  • Chart 21-4: Vascular Closure Device Market by Segment, Global, 2020 - 2030
  • Chart 21-5: Vascular Closure Device Market by Region, Global, 2020 - 2030
  • Chart 21-6: Leading Competitors, Vascular Closure Device Market, Global, 2023
  • Chart 22-1: Transcatheter Embolization Market, Global, 2023 & 2030
  • Chart 22-2: Transcatheter Embolization Procedures, Global, 2023
  • Chart 22-3: Transcatheter Embolization Procedures by Region, Global, 2020 - 2030
  • Chart 22-4: Transcatheter Embolization Market by Segment, Global, 2020 - 2030
  • Chart 22-5: Transcatheter Embolization Market by Region, Global, 2020 - 2030
  • Chart 22-6: Leading Competitors, Transcatheter Embolization Market, Global, 2023
  • Chart 23-1: Peripheral IVUS Market, Global, 2023 & 2030
  • Chart 23-2: Peripheral IVUS Procedures, Global, 2023
  • Chart 23-3: Peripheral IVUS Procedures by Region, Global, 2020 - 2030
  • Chart 23-4: Peripheral IVUS Market, Global, 2020 - 2030
  • Chart 23-5: Leading Competitors, Peripheral IVUS Market, Global, 2023

LIST OF FIGURES

  • Figure 1-1: Peripheral Vascular Device Market Share Ranking by Segment, Global, 2023 (1 of 4)
  • Figure 1-2: Peripheral Vascular Device Market Share Ranking by Segment, Global, 2023 (2 of 4)
  • Figure 1-3: Peripheral Vascular Device Market Share Ranking by Segment, Global, 2023 (3 of 4)
  • Figure 1-4: Peripheral Vascular Device Market Share Ranking by Segment, Global, 2023 (4 of 4)
  • Figure 1-5: Companies Researched in This Report
  • Figure 1-6: Factors Impacting the Peripheral Vascular Device Market by Segment, Global (1 of 4)
  • Figure 1-7: Factors Impacting the Peripheral Vascular Device Market by Segment, Global (2 of 4)
  • Figure 1-8: Factors Impacting the Peripheral Vascular Device Market by Segment, Global (3 of 4)
  • Figure 1-9: Factors Impacting the Peripheral Vascular Device Market by Segment, Global (4 of 4)
  • Figure 1-10: Recent Events in the Peripheral Vascular Device Market, Global, 2019 - 2023
  • Figure 1-11: Peripheral Vascular Procedures Covered (1 of 2)
  • Figure 1-12: Peripheral Vascular Procedures Covered (2 of 2)
  • Figure 1-13: Peripheral Vascular Device Markets Covered (1 of 3)
  • Figure 1-14: Peripheral Vascular Device Markets Covered (2 of 3)
  • Figure 1-15: Peripheral Vascular Device Markets Covered (3 of 3)
  • Figure 1-16: Peripheral Vascular Regions Covered, Global (1 of 2)
  • Figure 1-17: Peripheral Vascular Regions Covered, Global (2 of 2)
  • Figure 1-18: Version History
  • Figure 2-1: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Global, 2020 - 2030 (US$M) (1 of 3)
  • Figure 2-2: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Global, 2020 - 2030 (US$M) (2 of 3)
  • Figure 2-3: Peripheral Vascular Device Market by Segment, Worst Case Scenario, Global, 2020 - 2030 (US$M) (3 of 3)
  • Figure 2-4: Peripheral Vascular Device Market by Segment, Base Case Scenario, Global, 2020 - 2030 (US$M) (1 of 3)
  • Figure 2-5: Peripheral Vascular Device Market by Segment, Base Case Scenario, Global, 2020 - 2030 (US$M) (2 of 3)
  • Figure 2-6: Peripheral Vascular Device Market by Segment, Base Case Scenario, Global, 2020 - 2030 (US$M) (3 of 3)
  • Figure 2-7: Peripheral Vascular Device Market by Segment, Best Case Scenario, Global, 2020 - 2030 (US$M) (1 of 3)
  • Figure 2-8: Peripheral Vascular Device Market by Segment, Best Case Scenario, Global, 2020 - 2030 (US$M) (2 of 3)
  • Figure 2-9: Peripheral Vascular Device Market by Segment, Best Case Scenario, Global, 2020 - 2030 (US$M) (3 of 3)
  • Figure 4-1: Peripheral Vascular Stent by Company (1 of 2)
  • Figure 4-2: Peripheral Vascular Stent by Company (2 of 2)
  • Figure 4-3: PTA Balloon Catheter by Company (1 of 3)
  • Figure 4-4: PTA Balloon Catheter by Company (2 of 3)
  • Figure 4-5: PTA Balloon Catheter by Company (3 of 3)
  • Figure 4-6: Drug-Coated Balloon by Company
  • Figure 4-7: Atherectomy Device by Company (1 of 2)
  • Figure 4-8: Atherectomy Device by Company (2 of 2)
  • Figure 4-9: Lithotripsy Device by Company
  • Figure 4-10: Chronic Total Occlusion Device by Company
  • Figure 4-11: Surgical Graft by Company (1 of 2)
  • Figure 4-12: Surgical Graft by Company (2 of 2)
  • Figure 4-13: Stent Graft by Company
  • Figure 4-14: Embolic Protection Device by Company
  • Figure 4-15: Peripheral Thrombus Management by Company
  • Figure 4-16: Inferior Vena Cava Filter & Retrieval Device by Company (1 of 2)
  • Figure 4-17: Inferior Vena Cava Filter & Retrieval Device by Company (2 of 2)
  • Figure 4-18: Carotid Shunt by Company
  • Figure 4-19: Diagnostic and Interventional Catheters by Company (1 of 2)
  • Figure 4-20: Diagnostic and Interventional Catheters by Company (2 of 2)
  • Figure 4-21: Diagnostic and Interventional Guidewire by Company (1 of 3)
  • Figure 4-22: Diagnostic and Interventional Guidewire by Company (2 of 3)
  • Figure 4-23: Diagnostic and Interventional Guidewire by Company (3 of 3)
  • Figure 4-24: Introducer Sheath by Company (1 of 2)
  • Figure 4-25: Introducer Sheath by Company (2 of 2)
  • Figure 4-26: Vascular Closure Device by Company
  • Figure 4-27: Transcatheter Embolization Devices by Company (1 of 2)
  • Figure 4-28: Transcatheter Embolization Devices by Company (2 of 2)
  • Figure 4-29: Peripheral IVUS Catheter by Company
  • Figure 4-30: Class 2 Device Recall VENOVO Venous Stent System
  • Figure 4-31: Class 1 Device Recall VICI VENOUS STENT System
  • Figure 4-32: Class 2 Device Recall ELUVIA
  • Figure 4-33: Class 2 Device Recall PALMAZ GENESIS
  • Figure 4-34: Class 2 Device Recall S.M.A.R.T. Flex
  • Figure 4-35: Class 1 Device Recall PRECISE PRO RX CAROTID STENT Implant System
  • Figure 4-36: Class 2 Device Recall Cordis S.M.A.R.T. CONTROL /S.M.A.R.T. Vascular Stent System
  • Figure 4-37: Class 2 Device Recall S.M.A.R.T. Nitinol Stent System and the S.M.A.R.T. Control Nitinol Stent System
  • Figure 4-38: Class 2 Device Recall Cordis Precise Nitinol Stent System
  • Figure 4-39: Class 2 Device Recall Formula 418 Renal BalloonExpandable Stent
  • Figure 4-40: Class 2 Device Recall Zilver 635 Biliary Stent
  • Figure 4-41: Class 2 Device Recall Zilver 518 Biliary Stent
  • Figure 4-42: Class 1 Device Recall Atrium
  • Figure 4-43: Class 2 Device Recall Everflex Selfexpanding Peripheral Stent
  • Figure 4-44: Class 2 Device Recall Medtronic Abre
  • Figure 4-45: Class 2 Device Recall Medtronic Abre Venous Selfexpanding Sent System
  • Figure 4-46: Class 2 Device Recall ENROUTE Transcarotid Stent System
  • Figure 4-47: Class 2 Device Recall GORE VIABAHN VBX, BALLOON EXPANDABLE ENDOPROSTHESIS
  • Figure 4-48: Class 2 Device Recall Conquest PTA Balloon Dilatation Catheter
  • Figure 4-49: Class 2 Device Recall Conquest 40 PTA Dilatation Catheter
  • Figure 4-50: Class 2 Device Recall Cordis SABER PTA Balloon Dilation Catheter
  • Figure 4-51: Class 2 Device Recall Cordis POWERFLEX P3, PTA Dilation Catheter
  • Figure 4-52: Class 2 Device Recall Cordis MAXI LD PTA Dilatation Catheter
  • Figure 4-53: Class 2 Device Recall POWERFLEX PRO Percutaneous Transluminal Angioplasty (PTA) Catheter
  • Figure 4-54: Class 1 Device Recall ADVANCE ENFORCER 35 FOCAL FORCE PTA BALLOON CATHETER
  • Figure 4-55: Class 2 Device Recall Medtronic IN.PACT Admiral, Paclitaxelcoated PTA Balloon Catheter
  • Figure 4-56: Class 2 Device Recall Chameleon PTA Balloon Dilation Catheter
  • Figure 4-57: Class 2 Device Recall Boston Scientific ROTAPRO
  • Figure 4-58: Class 2 Device Recall STEALTH 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
  • Figure 4-59: Class 2 Device Recall DIAMONDBACK 360 GEN2 PERIPHERAL ORBITAL ATHERECTOMY SYSTEM
  • Figure 4-60: Class 1 Device Recall TurboHawk Plus
  • Figure 4-61: Class 1 Device Recall HawkOne
  • Figure 4-62: Class 2 Device Recall Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System
  • Figure 4-63: Class 1 Device Recall IntraClude IntraAortic Occlusion Device
  • Figure 4-64: Class 2 Device Recall Intergard Woven Vascular Graft
  • Figure 4-65: Class 2 Device Recall Interavascular SAS/Getinge
  • Figure 4-66: Class 2 Device Recall Hemashield Gold Knitted Bifurcated
  • Figure 4-67: Class 2 Device Recall Atrium ADVANTA VXT Vascular Graft
  • Figure 4-68: Class 2 Device Recall HEMASHIELD MICROVEL Double Velour Knitted Vascular Grafts
  • Figure 4-69: Class 2 Device Recall HEMASHIELD PLATINUM WOVEN/MICROVEL DOUBLE VELOUR VASCULAR GRAFTS
  • Figure 4-70: Class 2 Device Recall HEMASHIELD PLATINUM Woven Double Velour Vascular Graft
  • Figure 4-71: Class 2 Device Recall VASCUTEK/TERUMO
  • Figure 4-72: Class 2 Device Recall Gore Propaten Vascular Graft
  • Figure 4-73: Class 1 Device Recall ENDOLOGIX AFX2 Bifurcated Endograft System
  • Figure 4-74: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Proximal (Aortic) Extension Endograft
  • Figure 4-75: Class 1 Device Recall ENDOLOGIX AFX Endovascular AAA System
  • Figure 4-76: Class 1 Device Recall ENDOLOGIX AFX/AFX2, Limb (Iliac) Extension Endograft
  • Figure 4-77: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
  • Figure 4-78: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
  • Figure 4-79: Class 2 Device Recall Zenith Alpha SpiralZ Endovascular Leg
  • Figure 4-80: Class 2 Device Recall Zenith Alpha Abdominal Endovascular Graft
  • Figure 4-81: Class 2 Device Recall Endurant, Endurant II and Endurant IIs Stent Graft Systems
  • Figure 4-82: Class 2 Device Recall Endurant Stent Graft System
  • Figure 4-83: Class 2 Device Recall Endurant II Stent Graft System
  • Figure 4-84: Class 2 Device Recall Endurant II/IIs Stent Graft System
  • Figure 4-85: Class 2 Device Recall Endurant II/IIs Stent Graft System
  • Figure 4-86: Class 1 Device Recall Valiant Navion Thoracic Stent Graft System
  • Figure 4-87: Device Recall AngioJet Ultra 5000 A Console, Boston Scientific
  • Figure 4-88: Class 2 Device Recall EKOS
  • Figure 4-89: Class 2 Device Recall EkoSonic Endovascular Device
  • Figure 4-90: Class 2 Device Recall EKOS Control System
  • Figure 4-91: Class 2 Device Recall AngioJet Ultra Consoles Thrombectomy System
  • Figure 4-92: Class 1 Device Recall ArrowTrerotola PTD
  • Figure 4-93: Class 1 Device Recall ArrowTrerotola Percutaneous Thrombolytic Device
  • Figure 4-94: Class 1 Device Recall ArrowTrerotola OverTheWire PTD Kit Percutaneous Thrombolytic Device: 7FR
  • Figure 4-95: Class 3 Device Recall Cook
  • Figure 4-96: Class 3 Device Recall Cook Celect Platinum Vena Cava Filter Set
  • Figure 4-97: Class 2 Device Recall SoftVu Omni Flush Angiographic Catheter
  • Figure 4-98: Class 2 Device Recall SEEKER(R) Crossing Support Catheter
  • Figure 4-99: Class 1 Device Recall Imager II 5F Angiographic Catheter
  • Figure 4-100: Class 1 Device Recall SUPER TORQUE MB 5F PIG
  • Figure 4-101: Class 1 Device Recall CrossCath Support Catheter
  • Figure 4-102: Class 2 Device Recall Torcon NB Advantage
  • Figure 4-103: Class 2 Device Recall Amplatz extra Stiff Wire Guide
  • Figure 4-104: Class 2 Device Recall Bentson Wire Guide
  • Figure 4-105: Class 2 Device Recall Cope Mandril Wire Guide
  • Figure 4-106: Class 2 Device Recall Cope Mandril Wire Guide (Nitinol)
  • Figure 4-107: Class 2 Device Recall Coons Interventional Wire Guide
  • Figure 4-108: Class 2 Device Recall Lunderquist Ring Torque Wire Guide
  • Figure 4-109: Class 2 Device Recall Newton Wire Guide
  • Figure 4-110: Class 2 Device Recall Roadrunner PC Hydrophilic Wire Guide
  • Figure 4-111: Class 2 Device Recall Roadrunner PC Wire Guide (Nimble Floppy)
  • Figure 4-112: Class 2 Device Recall Roadrunner PC Wire Guide (The Firm)
  • Figure 4-113: Class 2 Device Recall Cook Roadrunner UniGlide Hydrophilic Wire Guide
  • Figure 4-114: Class 2 Device Recall Cook Roadrunner PC Wire Guide
  • Figure 4-115: Class 2 Device Recall Roadrunner Hydrophilic PC Wire Guide
  • Figure 4-116: Class 2 Device Recall Zurpaz(TM) MEDIUM CURL, ASYMMETRIC CURVE, Steerable Sheath
  • Figure 4-117: Class 2 Device Recall Ultimum HEMOSTASIS INTRODUCER
  • Figure 4-118: Class 2 Device Recall FastCath Trio HEMOSTASIS INTRODUCER
  • Figure 4-119: Class 2 Device Recall FastCath Hemostasis Introducer, HEMOSTASIS INTRODUCER
  • Figure 4-120: Class 2 Device Recall Avanti Catheter Sheath Introducer
  • Figure 4-121: Class 2 Device Recall
  • Figure 4-122: Class 2 Device Recall Flexor CheckFlo Introducer
  • Figure 4-123: Class 1 Device Recall Flexor CheckFlo Introducer
  • Figure 4-124: Class 2 Device Recall Hilal Embolization Microcoil
  • Figure 4-125: Class 2 Device Recall Nester Embolization Microcoil
  • Figure 4-126: Class 2 Device Recall Tornado Embolization Microcoil
  • Figure 4-127: Class 2 Device Recall Terumo AZUR Peripheral Coil System, Detachable 18
  • Figure 4-128: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 35, CX Coil
  • Figure 4-129: Class 2 Device Recall Terumo AZUR CX Peripheral Coil System, Detachable 18, CX Coil
  • Figure 4-130: Class 2 Device Recall OptiCross 35 15 MHz Peripheral Imaging Catheter
  • Figure 4-131: Peripheral Venous Stent System in the Treatment of Iliac Vein Stenosis or Occlusion
  • Figure 4-132: Belgian Trial Investigating the LifeStream Stent in Complex TASC C and D Iliac Lesions (BELSTREAM)
  • Figure 4-133: Paclitaxel-Coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses (XPEDITE)
  • Figure 4-134: An All-Comers Observational Study of the MicroStent™ Peripheral Vascular Stent System in Subjects with Peripheral Arterial Disease (HEAL)
  • Figure 4-135: SOLARIS Peripheral PMCF Trial
  • Figure 4-136: A Superiority Trial of the SUPERA Peripheral Stent System in Patients with Femoro-popliteal Artery Disease
  • Figure 4-137: Evaluation of Safety and Efficacy of the S.M.A.R.T. RADIANZ™ Vascular Stent System in the Treatment of Iliac and Femoropopliteal Lesions Via Transradial Access (RADIANCY)
  • Figure 4-138: Stella Supera Siberia
  • Figure 4-139: A Real World Evaluation of the ELUVIA Stent in Subjects with Lesions Located in the Femoropopliteal Arteries (REGAL)
  • Figure 4-140: Zilver® PTX® V Clinical Study
  • Figure 4-141: In-Stent Restenosis Post-Approval Study
  • Figure 4-142: BARD® The VENOVO™ Venous Stent Study for Treatment of Iliofemoral Occlusive Disease (VERNACULAR)
  • Figure 4-143: VIVO Clinical Study
  • Figure 4-144: ULTRASCORE™ Focused Force PTA Balloon Angioplasty for CLI Patients with Below the Knee Vessel Disease
  • Figure 4-145: Real World Registry Assessing the Clinical Use of the Bard UltraScore Forced Focus PTA Balloon
  • Figure 4-146: Ranger™ and Ranger™ SL (OTW) DCB in China
  • Figure 4-147: The VaSecure BTK Study
  • Figure 4-148: Comparison of the Ranger™ Paclitaxel-Coated PTA Balloon Catheter and Uncoated PTA Balloons in Femoropopliteal Arteries (RANGER-SFA)
  • Figure 4-149: A Trial to Evaluate the Safety and Efficacy of the Passeo-18 Lux Drug-coated Balloon of Biotronik in the Treatment of the Femoropopliteal Artery Compared to the Medtronic IN.PACT Admiral Drug-coated Balloon. (BIOPACT-RCT)
  • Figure 4-150: Safety and Efficacy of the SurVeil™ Drug-Coated Balloon (TRANSCEND)
  • Figure 4-151: RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty (RANGER II SFA)
  • Figure 4-152: IN.PACT BTK Randomized Study to Assess Safety and Efficacy of IN.PACT 014 vs. PTA
  • Figure 4-153: Compare I Pilot Study for the Treatment of Subjects with Symptomatic Femoropopliteal Artery Disease
  • Figure 4-154: ILLUMENATE Below-The-Knee (BTK) Arteries: a Post Market Clinical Study (BTK PMS)
  • Figure 4-155: IN.PACT Global Clinical Study
  • Figure 4-156: ILLUMENATE Pivotal Post-Approval Study (PAS)
  • Figure 4-157: BIOLUX P-III BENELUX All-Comers Registry
  • Figure 4-158: Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter (SAFE-DCB)
  • Figure 4-159: Safety and Effectiveness Evaluation of Peripheral Orbital Atherectomy (KAIZEN)
  • Figure 4-160: Jetstream in Treatment of Occlusive Atherosclerotic Lesions in the SFA and/or PPA
  • Figure 4-161: Revascularization of Total or Sub-total Occluded Peripheral Arteries with ByCross® Device. Post Market Clinical Follow-up
  • Figure 4-162: Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected with Infrainguinal Peripheral Artery Disease (PATHFINDER-I)
  • Figure 4-163: JET-RANGER Trial - JETStream Atherectomy With Adjunctive Paclitaxel-Coated Balloon Angioplasty vs Plain Old Balloon Angioplasty Followed by Paclitaxel-Coated Balloon
  • Figure 4-164: Pantheris Atherectomy Treatment of In-Stent Restenosis in Lower Extremity Arteries (INSIGHT)
  • Figure 4-165: Safety and Effectiveness Study of Eximo's B-Laser™ Atherectomy Device for PAD Treatment
  • Figure 4-166: Safety and Effectiveness of Jetstream Atherectomy System (J-SUPREME II)
  • Figure 4-167: DiRectional AthErectomy + Drug CoAted BaLloon to Treat Long, CalcifIed FemoropopliTeal ArterY Lesions (REALITY)
  • Figure 4-168: Mini S Feasibility Study with Shockwave Medical Mini S Peripheral IVL System
  • Figure 4-169: SOLUTION Trial in China
  • Figure 4-170: Disrupt PAD+ Study with the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+)
  • Figure 4-171: Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
  • Figure 4-172: A Prospective and Retrospective, Multi-Centre, Post-Market, Non-Interventional Study of Terumo Aortic Knitted and Woven Grafts, and Cardiovascular Patches (PANTHER)
  • Figure 4-173: Retrospective Post-Market Clinical Follow-Up Study of GORE-TEX® Vascular Grafts and GORE® PROPATEN® Vascular Graft in Peripheral Artery Disease, Aortic Aneurysms, and Dialysis Access
  • Figure 4-174: Ankura™ TAA Stent Graft System Post-Market Clinical Follow-up Study
  • Figure 4-175: Post-Approval Study of the TREO Abdominal Stent-Graft System (TREO PAS)
  • Figure 4-176: The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease
  • Figure 4-177: Zenith Alpha™ Abdominal Endovascular Graft
  • Figure 4-178: Fenestrated AAA Endovascular Graft Post-Approval Study
  • Figure 4-179: transShield Embolic Protection System Feasibility Study
  • Figure 4-180: Study of the Long-Term Safety and Outcomes of Treating Pulmonary Embolism with the Indigo Aspiration System
  • Figure 4-181: Preservation of Venous Valvular Function After PMT for Acute DVT (PREFER)
  • Figure 4-182: A Study of Patients with Lower Extremity Acute Limb Ischemia to Remove Thrombus with the Indigo Aspiration System (STRIDE)
  • Figure 4-183: FlowTriever All-Comer Registry for Patient Safety and Hemodynamics (FLASH)
  • Figure 4-184: JETi Peripheral Thrombectomy Registry (JETi)
  • Figure 4-185: Treatment of Low-Risk Submassive Pulmonary Embolism with FlowTriever
  • Figure 4-186: Forceps vs. Snare IVC Filter Removal
  • Figure 4-187: Predictors of Attempted Inferior Vena Cava Filters Retrieval
  • Figure 4-188: Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter
  • Figure 4-189: Cook IVC Filter Study (CIVC)
  • Figure 4-190: Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE)
  • Figure 4-191: Evaluation of Safety and Efficacy of the Mynx Control Venous Vascular Closure Device 6F-12F vs Manual Compression (ReliaSeal)
  • Figure 4-192: AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial
  • Figure 4-193: Vascular Closure Device in Transcatheter Aortic Valve Replacement
  • Figure 4-194: Manta™ Versus Suture-based Closure After Transcatheter Aortic Valve Implantation Trial (MASH-TAVI)
  • Figure 4-195: Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device (PANDA)
  • Figure 4-196: (HALT) Embrace Hydrogel Embolic System (HES) Study of Embolization in Peripheral Arterial Bleeds
  • Figure 4-197: Microvascular Plug (MVP) for the Treatment of Pulmonary ArterioVenous Malformations (PAVMs)
  • Figure 4-198: Use of Interlocking Detachable Coils System in Embolization of Peripheral Arterial Embolization
  • Figure 4-199: CATERPILLAR™ Arterial Embolization Device Study (CHRYSALIS)
  • Figure 4-200: LC Bead LUMI for Prostatic Artery Embolization
  • Figure 5-1: Peripheral Vascular Device Market by Segment, Global, 2020 - 2030 (US$M) (1 of 3)
  • Figure 5-2: Peripheral Vascular Device Market by Segment, Global, 2020 - 2030 (US$M) (2 of 3)
  • Figure 5-3: Peripheral Vascular Device Market by Segment, Global, 2020 - 2030 (US$M) (3 of 3)
  • Figure 5-4: Peripheral Vascular Device Market by Region, Global, 2020 - 2030 (US$M)
  • Figure 5-5: Leading Competitors, Peripheral Vascular Device Market by Segment, Global, 2023 (1 of 4)
  • Figure 5-6: Leading Competitors, Peripheral Vascular Device Market by Segment, Global, 2023 (2 of 4)
  • Figure 5-7: Leading Competitors, Peripheral Vascular Device Market by Segment, Global, 2023 (3 of 4)
  • Figure 5-8: Leading Competitors, Peripheral Vascular Device Market by Segment, Global, 2023 (4 of 4)
  • Figure 5-9: SWOT Analysis, Abbott (1 of 2)
  • Figure 5-10: SWOT Analysis, Abbott (2 of 2)
  • Figure 5-11: SWOT Analysis, Becton Dickinson (1 of 2)
  • Figure 5-12: SWOT Analysis, Becton Dickinson (2 of 2)
  • Figure 5-13: SWOT Analysis, Boston Scientific
  • Figure 5-14: SWOT Analysis, Cardinal Health
  • Figure 5-15: SWOT Analysis, Cardiovascular Systems, Inc.
  • Figure 5-16: SWOT Analysis, Cook Medical
  • Figure 5-17: SWOT Analysis, Medtronic
  • Figure 5-18: SWOT Analysis, Penumbra
  • Figure 5-19: SWOT Analysis, Philips
  • Figure 5-20: SWOT Analysis, Shockwave Medical
  • Figure 5-21: SWOT Analysis, Silk Road Medical
  • Figure 5-22: SWOT Analysis, Terumo (1 of 2)
  • Figure 5-23: SWOT Analysis, Terumo (2 of 2)
  • Figure 5-24: SWOT Analysis, W.L. Gore
  • Figure 6-1: Peripheral Vascular Stent Procedures Covered
  • Figure 6-2: Peripheral Vascular Stent Markets Covered
  • Figure 6-3: Peripheral Vascular Stent Regions Covered, Global (1 of 2)
  • Figure 6-4: Peripheral Vascular Stent Regions Covered, Global (2 of 2)
  • Figure 6-5: Peripheral Vascular Stenting Procedures by Segment, Global, 2020 - 2030
  • Figure 6-6: Peripheral Vascular Stenting Procedures by Region, Global, 2020 - 2030
  • Figure 6-7: Peripheral Vascular Stenting Procedures by Country, North America, 2020 - 2030
  • Figure 6-8: Peripheral Vascular Stenting Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-9: Peripheral Vascular Stenting Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-10: Peripheral Vascular Stenting Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-11: Peripheral Vascular Stenting Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-12: Peripheral Vascular Stenting Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-13: Peripheral Vascular Stenting Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-14: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-15: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-16: Peripheral Vascular Stenting Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-17: Peripheral Vascular Stenting Procedures by Country, Africa, 2020 - 2030
  • Figure 6-18: Arterial Stent Procedures by Segment, Global, 2020 - 2030
  • Figure 6-19: Arterial Stent Procedures by Region, Global, 2020 - 2030
  • Figure 6-20: Arterial Stent Procedures by Country, North America, 2020 - 2030
  • Figure 6-21: Arterial Stent Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-22: Arterial Stent Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-23: Arterial Stent Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-24: Arterial Stent Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-25: Arterial Stent Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-26: Arterial Stent Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-27: Arterial Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-28: Arterial Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-29: Arterial Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-30: Arterial Stent Procedures by Country, Africa, 2020 - 2030
  • Figure 6-31: Bare-Metal Stent Procedures by Region, Global, 2020 - 2030
  • Figure 6-32: Bare-Metal Stent Procedures by Country, North America, 2020 - 2030
  • Figure 6-33: Bare-Metal Stent Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-34: Bare-Metal Stent Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-35: Bare-Metal Stent Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-36: Bare-Metal Stent Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-37: Bare-Metal Stent Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-38: Bare-Metal Stent Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-39: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-40: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-41: Bare-Metal Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-42: Bare-Metal Stent Procedures by Country, Africa, 2020 - 2030
  • Figure 6-43: Covered Stent Procedures by Region, Global, 2020 - 2030
  • Figure 6-44: Covered Stent Procedures by Country, North America, 2020 - 2030
  • Figure 6-45: Covered Stent Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-46: Covered Stent Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-47: Covered Stent Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-48: Covered Stent Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-49: Covered Stent Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-50: Covered Stent Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-51: Covered Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-52: Covered Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-53: Covered Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-54: Covered Stent Procedures by Country, Africa, 2020 - 2030
  • Figure 6-55: Drug-Eluting Stent Procedures by Region, Global, 2020 - 2030
  • Figure 6-56: Drug-Eluting Stent Procedures by Country, North America, 2020 - 2030
  • Figure 6-57: Drug-Eluting Stent Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-58: Drug-Eluting Stent Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-59: Drug-Eluting Stent Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-60: Drug-Eluting Stent Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-61: Drug-Eluting Stent Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-62: Drug-Eluting Stent Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-63: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-64: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-65: Drug-Eluting Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-66: Drug-Eluting Stent Procedures by Country, Africa, 2020 - 2030
  • Figure 6-67: Venous Stent Procedures by Region, Global, 2020 - 2030
  • Figure 6-68: Venous Stent Procedures by Country, North America, 2020 - 2030
  • Figure 6-69: Venous Stent Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 6-70: Venous Stent Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 6-71: Venous Stent Procedures by Country, Western Europe, 2020 - 2030
  • Figure 6-72: Venous Stent Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 6-73: Venous Stent Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 6-74: Venous Stent Procedures by Country, Middle East, 2020 - 2030
  • Figure 6-75: Venous Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 6-76: Venous Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 6-77: Venous Stent Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 6-78: Venous Stent Procedures by Country, Africa, 2020 - 2030
  • Figure 6-79: Peripheral Vascular Stent Market by Segment, Global, 2020 - 2030 (US$M)
  • Figure 6-80: Peripheral Vascular Stent Market by Region, Global, 2020 - 2030 (US$M)
  • Figure 6-81: Arterial Stent Market by Segment, Global, 2020 - 2030 (US$M)
  • Figure 6-82: Total Arterial Stent Market, Global, 2020 - 2030
  • Figure 6-83: Units Sold by Region, Arterial Stent Market, Global, 2020 - 2030
  • Figure 6-84: Average Selling Price by Region, Arterial Stent Market, Global, 2020 - 2030 (US$)
  • Figure 6-85: Market Value by Region, Arterial Stent Market, Global, 2020 - 2030 (US$M)
  • Figure 6-86: Bare-Metal Stent Market by Segment, Global, 2020 - 2030 (US$M)
  • Figure 6-87: Total Bare-Metal Stent Market, Global, 2020 - 2030
  • Figure 6-88: Units Sold by Region, Bare-Metal Stent Market, Global, 2020 - 2030
  • Figure 6-89: Average Selling Price by Region, Bare-Metal Stent Market, Global, 2020 - 2030 (US$)
  • Figure 6-90: Market Value by Region, Bare-Metal Stent Market, Global, 2020 - 2030 (US$M)
  • Figure 6-91: Bare-Metal Carotid Stent Market, Global, 2020 - 2030
  • Figure 6-92: Units Sold by Region, Bare-Metal Carotid Stent Market, Global, 2020 - 2030
  • Figure 6-93: Average Selling Price by Region, Bare-Metal Carotid Stent Market, Global, 2020 - 2030 (US$)
  • Figure 6-94: Market Value by Region, Bare-Metal Carotid Stent Market, Global, 2020 - 2030 (US$M)
  • Figure 6-95: Bare-Metal Iliac Stent Market, Global, 2020 - 2030
  • Figure 6-96: Units Sold by Region, Bare-Metal Iliac Stent Market, Global, 2020 - 2030
  • Figure 6-97: Average Selling Price by Region, Bare-Metal Iliac Stent Market, Global, 2020 - 2030 (US$)
  • Figure 6-98: Market Value by Region, Bare-Metal Iliac Stent Market, Global, 2020 - 2030 (US$M)
  • Figure 6-99: Bare-Metal Renal Stent Market, Global, 2020 - 2030
  • Figure 6-100: Units Sold by Region, Bare-Metal Renal Stent Market, Global, 2020 - 2030
  • Figure 6-101: Average Selling Price by Region, Bare-Metal Renal Stent Market, Global, 2020 - 2030 (US$)
  • Figure 6-102: Market Value by Region, Bare-Metal Renal Stent Market, Global, 2020 - 2030 (US$M)
  • Figure 6-103: Bare-Metal Fem-Pop Stent Market, Global, 2020 - 2030
  • Figure 6-104: Units Sold by Region, Bare-Metal Fem-Pop Stent Market, Global, 2020 - 2030
  • Figure 6-105: Average Selling Price by Region, Bare-Metal Fem-Pop Stent Market, Global, 2020 - 2030 (US$)
  • Figure 6-106: Market Value by Region, Bare-Metal Fem-Pop Stent Market, Global, 2020 - 2030 (US$M)
  • Figure 6-107: Bare-Metal Infra-Pop Stent Market, Global, 2020 - 2030
  • Figure 6-108: Units Sold by Region, Bare-Metal Infra-Pop Stent Market, Global, 2020 - 2030
  • Figure 6-109: Average Selling Price by Region, Bare-Metal Infra-Pop Stent Market, Global, 2020 - 2030 (US$)
  • Figure 6-110: Market Value by Region, Bare-Metal Infra-Pop Stent Market, Global, 2020 - 2030 (US$M)
  • Figure 6-111: Covered Stent Market, Global, 2020 - 2030
  • Figure 6-112: Units Sold by Region, Covered Stent Market, Global, 2020 - 2030
  • Figure 6-113: Average Selling Price by Region, Covered Stent Market, Global, 2020 - 2030 (US$)
  • Figure 6-114: Market Value by Region, Covered Stent Market, Global, 2020 - 2030 (US$M)
  • Figure 6-115: Drug-Eluting Stent Market, Global, 2020 - 2030
  • Figure 6-116: Units Sold by Region, Drug-Eluting Stent Market, Global, 2020 - 2030
  • Figure 6-117: Average Selling Price by Region, Drug-Eluting Stent Market, Global, 2020 - 2030 (US$)
  • Figure 6-118: Market Value by Region, Drug-Eluting Stent Market, Global, 2020 - 2030 (US$M)
  • Figure 6-119: Venous Stent Market, Global, 2020 - 2030
  • Figure 6-120: Units Sold by Region, Venous Stent Market, Global, 2020 - 2030
  • Figure 6-121: Average Selling Price by Region, Venous Stent Market, Global, 2020 - 2030 (US$)
  • Figure 6-122: Market Value by Region, Venous Stent Market, Global, 2020 - 2030 (US$M)
  • Figure 6-123: Leading Competitors, Peripheral Vascular Stent Market, Global, 2023
  • Figure 7-1: PTA Balloon Procedures Covered
  • Figure 7-2: PTA Balloon Markets Covered
  • Figure 7-3: PTA Balloon Regions Covered, Global (1 of 2)
  • Figure 7-4: PTA Balloon Regions Covered, Global (2 of 2)
  • Figure 7-5: PTA Balloon Procedures by Region, Global, 2020 - 2030
  • Figure 7-6: PTA Balloon Procedures by Country, North America, 2020 - 2030
  • Figure 7-7: PTA Balloon Procedures by Country, Latin America, 2020 - 2030 (1 of 2)
  • Figure 7-8: PTA Balloon Procedures by Country, Latin America, 2020 - 2030 (2 of 2)
  • Figure 7-9: PTA Balloon Procedures by Country, Western Europe, 2020 - 2030
  • Figure 7-10: PTA Balloon Procedures by Country, Central & Eastern Europe, 2020 - 2030 (1 of 2)
  • Figure 7-11: PTA Balloon Procedures by Country, Central & Eastern Europe, 2020 - 2030 (2 of 2)
  • Figure 7-12: PTA Balloon Procedures by Country, Middle East, 2020 - 2030
  • Figure 7-13: PTA Balloon Procedures by Country, Asia-Pacific, 2020 - 2030 (1 of 3)
  • Figure 7-14: PTA Balloon Procedures by Country, Asia-Pacific, 2020 - 2030 (2 of 3)
  • Figure 7-15: PTA Balloon Procedures by Country, Asia-Pacific, 2020 - 2030 (3 of 3)
  • Figure 7-16: PTA Balloon Procedures by Country, Africa, 2020 - 2030
  • Figure 7-17: PTA Balloon Market by Segment, Global, 2020 - 2030 (US$M)
  • Figure 7-18: PTA Balloon Market by Region, Global, 2020 - 2030 (US$M)
  • Figure 7-19: PTA Balloon Market, Global, 2020 - 2030
  • Figure 7-20: Units Sold by Region, PTA Balloon Market, Global, 2020 - 2030
  • Figure 7-21: Average Selling Price by Region, PTA Balloon Market, Global, 2020 - 2030 (US$)
  • Figure 7-22: Market Value by Region, PTA Balloon Market, Global, 2020 - 2030 (US$M)
  • Figure 7-23: Standard PTA Balloon Market, Global, 2020 - 2030
  • Figure 7-24: Units Sold by Region, Standard PTA Balloon Market, Global, 2020 - 2030
  • Figure 7-25: Average Selling Price by Region, Standard PTA Balloon Market, Global, 2020 - 2030 (US$)
  • Figure 7-26: Market Value by Region, Standard PTA Balloon Market, Global, 2020 - 2030 (US$M)
  • Figure 7-27: High-Pressure PTA Balloon Market, Global, 2020 - 2030
  • Figure 7-28: Units Sold by Region, High-Pressure PTA Balloon Market, Global, 2020 - 2030
  • Figure 7-29: Average Selling Price by Region, High-Pressure PTA Balloon Market, Global, 2020 - 2030 (US$)
  • Figure 7-30: Market Value by Region, High-Pressure PTA Balloon Market, Global, 2020 - 2030 (US$M)
  • Figure 7-31: Large PTA Balloon Market, Global, 2020 - 2030
  • Figure 7-32: Units Sold by Region, Large PTA Balloon Market, Global, 2020 - 2030
  • Figure 7-33: Average Selling Price by Region, Large PTA Balloon Market, Global, 2020 - 2030 (US$)
  • Figure 7-34: Market Value by Region, Large PTA Balloon Market, Global, 2020 - 2030 (US$M)
  • Figure 7-35: Small PTA Balloon Ma
目次
Product Code: iDATA_GLPV24_MS

In 2023, the global peripheral vascular device market achieved a valuation of $12.9 billion, with an anticipated growth rate of 4.4% over the forecast period, reaching over $17.4 billion.

Our extensive medical market research involved the analysis of over 60 peripheral vascular companies globally, utilizing a comprehensive methodology to gain insights into market sizes, unit sales, company market shares, and to craft accurate forecasts.

While this MedSuite report presents a comprehensive view of the peripheral vascular market, each market segment is also available as individual MedCore reports. This flexibility allows you to access precisely the market research that aligns with your specific needs

DATA TYPES INCLUDED

  • Procedure Numbers, Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2029, and Historical Data to 2019
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • COVID19 Impact
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios and SWOT for Top Competitors

GLOBAL PERIPHERAL VASCULAR MARKET INSIGHTS

An emerging trend in the peripheral vascular (PV) market revolves around the increasing adoption of state-of-the-art technologies and minimally invasive techniques for PV procedures. These advancements involve the utilization of catheter-based treatments and a range of devices, including Drug-Coated Balloons (DCBs), atherectomy devices, and stent grafts. These cutting-edge technologies offer numerous benefits compared to traditional surgical methods, including shorter recovery periods, reduced patient discomfort, and improved clinical outcomes. With ongoing investments from both medical device firms and healthcare providers in novel technologies and strategies, the PV market is poised for further evolution, with a heightened focus on patient outcomes, cost-efficiency, and innovation.

GLOBAL PERIPHERAL VASCULAR MARKET SHARE INSIGHTS

In 2023, Medtronic maintained its global market leadership, dominating the stent graft market and showcasing excellence in Drug-Coated Balloons (DCBs), CTO devices, and embolic protection devices. With an extensive product portfolio, Medtronic held substantial shares in high-value markets, strategically bundling products to enhance its overall market presence. Notable offerings included Admiral IN.PACT™ DCBs, as well as the Endurant™ and Valiant™ stent grafts, while other stents and PTA balloons significantly contributed to its revenue.

W.L. Gore emerged as a key player in the stent, surgical graft, and stent graft markets in 2023, securing a leading position in high-value peripheral vascular segments. The company's expanding device portfolio, especially with the introduction of the ACTIVE CONTROL release, is poised to increase its market share over the forecast period.

Following its merger with BTG in 2019, Boston Scientific claimed the third position globally. Strengthening its venous treatment and transcatheter embolization portfolios, the company secured top positions in these markets. With a comprehensive portfolio for treating venous diseases, Boston Scientific is anticipated to gain market share in the total peripheral vascular market over time.

MARKET SEGMENTATION SUMMARY

While this global report suite contains all global ophthalmic device market data, each of the market segments is also available as a stand-alone report, MedCore. This allows you to get access to only the infusion therapy market research that you need.

Peripheral Vascular Stent Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Arterial Stents (Bare-Metal Stents, Covered Stents, and Drug-Eluting Stents), Venous Stents
  • Market Segments: Arterial Stents (Bare-Metal Stents, Covered Stents, and Drug-Eluting Stents), and Venous Stents.

Percutaneous Transluminal Angioplasty Balloon Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: PTA Balloon Procedures
  • Market Segments: Standard PTA Balloon Catheters, High-Pressure PTA Balloon Catheters, Large PTA Balloon Catheter, Small PTA Balloon Catheter, and Specialty PTA Balloon Catheters.

Drug-Coated Balloon Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Drug-Coated Balloon Procedures
  • Market Segments: Drug-Coated Balloons

Atherectomy Device Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Atherectomy Procedures
  • Market Segments: Laser Atherectomy Devices and Mechanical Atherectomy Devices

Intravascular Lithotripsy Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Intravascular Lithotripsy Procedures
  • Market Segments: Intravascular Lithotripsy

Chronic Total Occlusion Device Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Re-Entry Procedures and Recanalization Procedures
  • Market Segments: Re-Entry Devices and Recanalization Devices

Surgical Graft Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Lower-Limb Surgical Graft, Aorta Repair Surgical Graft, and Extra-Anatomical Bypass Surgical Graft Procedures.
  • Market Segments: Lower-Limb Surgical Grafts, Aorta Repair Surgical Grafts, Extra-Anatomical Bypass Surgical Grafts.

Stent Graft Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: AAA Stent Graft, Fenestrated Stent Graft, TAA Stent Graft Procedures.
  • Market Segments: AAA Stent Grafts, Fenestrated Stent Grafts, TAA Stent Grafts.

Embolic Protection Device Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Embolic Protection Device Procedures
  • Market Segments: Carotid Embolic Protection Devices, Renal Embolic Protection Devices, and Lower-Limb Embolic Protection Devices.

Peripheral Thrombus Management Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Peripheral Thrombus Management Procedures
  • Market Segments: Traditional Thrombectomy Devices, and Pharmacomechanical Thrombectomy Devices.

Carotid Shunt Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Carotid Endarterectomy Procedures
  • Market Segments: Carotid Shunts.

Diagnostic and Interventional Catheter Market | Global | 2024-2030 | MedCore -- Includes:

  • Market Segments: Diagnostic Catheters (Standard and Hydrophilic), and Support Catheters.

Diagnostic and Interventional Guidewire Market | Global | 2024-2030 | MedCore -- Includes:

  • Market Segments: Standard Guidewires and Hydrophilic Guidewires.

Introducer Sheath Market | Global | 2024-2030 | MedCore -- Includes:

Vascular Closure Device Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Invasive VCD and Non-Invasive VCD.
  • Market Segments: Invasive VCD (Small-Bore and Large-Bore Invasive VCDs) and Non-Invasive VCDs.

Transcatheter Embolization Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Particle Embolization and Coil Embolization.
  • Market Segments: Particle Embolization (PVA Particles, Drug-Eluting Particles, Radioactive Particles, Microspheres) and Coil Embolization.

Peripheral Intravenous Ultrasound Market | Global | 2024-2030 | MedCore -- Includes:

  • Procedures: Peripheral IVUS Procedures
  • Market Segments: Peripheral IVUS.

GLOBAL RESEARCH SCOPE SUMMARY

  • Regions : North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
  • Base Year: 2023
  • Forecast: 2024-2030
  • Historical Data: 2020-2023
  • Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
  • Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
  • Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

Table of Contents

List of Figures

List of Charts

Executive summary

  • Global Peripheral Vascular Device Market Overview
  • Competitive Analysis
  • Market Trends
  • Market Developments
  • Procedures Included
  • Markets Included
  • Regions Included
  • Version History

Research methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

impact of covid-19 on THE global Peripheral vascular DEVICE Market

  • 2.1. Introduction
  • 2.2. Regional Profiles
  • 2.3. Analysis By Market Segment
    • 2.3.1. Worst Case Scenario
    • 2.3.2. Base Case Scenario
    • 2.3.3. Best Case Scenario

Disease Overview

  • 3.1. Basic Anatomy
  • 3.2. Disease Treatments & Diagnostics
    • 3.2.1. Aortic Aneurysms
    • 3.2.2. Atherosclerosis
    • 3.2.3. Peripheral Arterial Disease (PAD)
    • 3.2.4. Deep Vein Thrombosis
    • 3.2.5. Pulmonary Embolism
  • 3.3. Patient Demographics
    • 3.3.1. Aortic Aneurysms
    • 3.3.2. Atherosclerosis
    • 3.3.3. Peripheral Arterial Disease (PAD)
    • 3.3.4. Deep Vein Thrombosis
    • 3.3.5. Pulmonary Embolism

Product Assessment

  • 4.1. Introduction
  • 4.2. Product Portfolios
    • 4.2.1. Peripheral Vascular Stent
    • 4.2.2. PTA Balloon Catheter
    • 4.2.3. Drug-Coated Balloon
    • 4.2.4. Atherectomy Device
    • 4.2.5. Intravascular Lithotripsy Market
    • 4.2.6. Chronic Total Occlusion
    • 4.2.7. Surgical Graft
    • 4.2.8. Stent Graft
    • 4.2.9. Embolic Protection
    • 4.2.10. Peripheral Thrombus Management
    • 4.2.11. Inferior Vena Cava Filter and Retrieval
    • 4.2.12. Carotid Shunt
    • 4.2.13. Diagnostic and Interventional Catheter
    • 4.2.14. Diagnostic and Interventional Guidewire
    • 4.2.15. Introducer Sheath
    • 4.2.16. Vascular Closure Device
    • 4.2.17. Transcatheter Embolization Device
    • 4.2.18. Peripheral IVUS Catheter
  • 4.3. Regulatory Issues and Recalls
    • 4.3.1. Peripheral Vascular Stent
    • 4.3.2. PTA Balloon Catheter
    • 4.3.3. Atherectomy Device
    • 4.3.4. Intravascular Lithotripsy Market
    • 4.3.5. Chronic Total Occlusion
    • 4.3.6. Surgical Graft
    • 4.3.7. Stent Graft
    • 4.3.8. Peripheral Thrombus Management Devices
    • 4.3.9. Inferior Vena Cava Filter & Retrieval
    • 4.3.10. Diagnostic & Interventional Catheter
    • 4.3.11. Diagnostic & Interventional Guidewire
    • 4.3.12. Introducer Sheaths
    • 4.3.13. Transcatheter Embolization Device
    • 4.3.14. Peripheral IVUS Catheter
  • 4.4. Clinical Trials
    • 4.4.1. Peripheral Vascular Stent
    • 4.4.2. PTA Balloon Catheter
    • 4.4.3. Drug-Coated Balloon
    • 4.4.4. Atherectomy Device
    • 4.4.5. Intravascular Lithotripsy
    • 4.4.6. Surgical Graft
    • 4.4.7. Stent Graft
    • 4.4.8. Embolic Protection
    • 4.4.9. Peripheral Thrombus Management
    • 4.4.10. Inferior Vena Cava Filter & Retrieval
    • 4.4.11. Vascular Closure Device
    • 4.4.12. Transcatheter Embolization Device

Global Peripheral Vascular device Market Overview

  • 5.1. Introduction
    • 5.1.1. Atherosclerosis
    • 5.1.2. Peripheral Arterial Disease
  • 5.2. Market Overview & Trend Analysis
    • 5.2.1. By Segment
    • 5.2.2. By Region
      • 5.2.2.1. Global Trends
      • 5.2.2.2. North America
      • 5.2.2.3. Latin America
      • 5.2.2.4. Western Europe
      • 5.2.2.5. Central and Eastern Europe
      • 5.2.2.6. Middle East
      • 5.2.2.7. Asia-Pacific
      • 5.2.2.8. Africa
  • 5.3. Drivers and Limiters
    • 5.3.1. Market Drivers
    • 5.3.2. Market Limiters
  • 5.4. Competitive Market Share Analysis
  • 5.5. Mergers and Acquisitions
  • 5.6. Company Profiles
    • 5.6.1. Abbott
    • 5.6.2. Becton Dickinson
    • 5.6.3. Boston Scientific
    • 5.6.4. Cardinal Health
    • 5.6.5. Cardiovascular Systems, Inc.
    • 5.6.6. Cook Medical
    • 5.6.7. Medtronic
    • 5.6.8. Penumbra
    • 5.6.9. Philips
    • 5.6.10. Shockwave Medical
    • 5.6.11. Silk Road Medical
    • 5.6.12. Terumo
    • 5.6.13. W.L. Gore
  • 5.7. SWOT Analysis
    • 5.7.1. Abbott
    • 5.7.2. Becton Dickinson
    • 5.7.3. Boston Scientific
    • 5.7.4. Cardinal Health
    • 5.7.5. Cardiovascular Systems, Inc.
    • 5.7.6. Cook Medical
    • 5.7.7. Medtronic
    • 5.7.8. Penumbra
    • 5.7.9. Philips
    • 5.7.10. Shockwave Medical
    • 5.7.11. Silk Road Medical
    • 5.7.12. Terumo
    • 5.7.13. W.L. Gore

peripheral vascular stent Market

  • 6.1. Executive Summary
    • 6.1.1. Global Peripheral Vascular Stent Market Overview
    • 6.1.2. Competitive Analysis
    • 6.1.3. Procedures Included
    • 6.1.4. Markets Included
    • 6.1.5. Regions Included
  • 6.2. Introduction
    • 6.2.1. Peripheral Arterial Stents
      • 6.2.1.1. Off-Label Use
      • 6.2.1.2. Covered Stents
      • 6.2.1.3. Drug-Eluting Stents
      • 6.2.1.4. Stent Length
    • 6.2.2. Venous Stents
  • 6.3. Procedure Numbers
    • 6.3.1. Total Peripheral Vascular Stenting Procedures
    • 6.3.2. Arterial Stent Procedures
      • 6.3.2.1. Bare-Metal Stent Procedures
      • 6.3.2.2. Covered Stent Procedures
      • 6.3.2.3. Drug-Eluting Stent Procedures
    • 6.3.3. Venous Stent Procedures
  • 6.4. Market Overview
    • 6.4.1. By Segment
    • 6.4.2. By Region
  • 6.5. Market Analysis and Forecast
    • 6.5.1. Arterial Stent Market
      • 6.5.1.1. Bare-Metal Stent Market
      • 6.5.1.1.1. Bare-Metal Carotid Stent Market
      • 6.5.1.1.2. Bare-Metal Iliac Stent Market
      • 6.5.1.1.3. Bare-Metal Renal Stent Market
      • 6.5.1.1.4. Bare-Metal Fem-Pop Stent Market
      • 6.5.1.1.5. Bare-Metal Infra-Pop Stent Market
      • 6.5.1.2. Covered Stent Market
      • 6.5.1.3. Drug-Eluting Stent Market
    • 6.5.2. Venous Stent Market
  • 6.6. Drivers and Limiters
    • 6.6.1. Market Drivers
    • 6.6.2. Market Limiters
  • 6.7. Competitive Market Share Analysis

PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY balloon Market

  • 7.1. Executive Summary
    • 7.1.1. Global Percutaneous Transluminal Angioplasty Balloon Market Overview
    • 7.1.2. Competitive Analysis
    • 7.1.3. Procedures Included
    • 7.1.4. Markets Included
    • 7.1.5. Regions Included
  • 7.2. Introduction
    • 7.2.1. Types of PTA Balloon Catheters
  • 7.3. Procedure Numbers
  • 7.4. Market Overview
    • 7.4.1. By Segment
    • 7.4.2. By Region
  • 7.5. Market Analysis and Forecast
    • 7.5.1. Total PTA Balloon Market
    • 7.5.2. Standard PTA Balloon Market
    • 7.5.3. High-Pressure PTA Balloon Market
    • 7.5.4. Large PTA Balloon Market
    • 7.5.5. Small PTA Balloon Market
    • 7.5.6. Specialty PTA Balloon Market
  • 7.6. Drivers and Limiters
    • 7.6.1. Market Drivers
    • 7.6.2. Market Limiters
  • 7.7. Competitive Market Share Analysis

Drug-Coated Balloon Market

  • 8.1. Executive Summary
    • 8.1.1. Global Drug-Coated Balloon Market Overview
    • 8.1.2. Competitive Analysis
    • 8.1.3. Procedures Included
    • 8.1.4. Regions Included
  • 8.2. Introduction
  • 8.3. Procedure Numbers
  • 8.4. Market Analysis and Forecast
  • 8.5. Drivers and Limiters
    • 8.5.1. Market Drivers
    • 8.5.2. Market Limiters
  • 8.6. Competitive Market Share Analysis

Atherectomy device Market

  • 9.1. Executive Summary
    • 9.1.1. Global Atherectomy Device Market Overview
    • 9.1.2. Competitive Analysis
    • 9.1.3. Procedures Included
    • 9.1.4. Markets Included
    • 9.1.5. Regions Included
  • 9.2. Introduction
  • 9.3. Procedure Numbers
  • 9.4. Market Overview
    • 9.4.1. By Segment
    • 9.4.2. By Region
  • 9.5. Market Analysis and Forecast
    • 9.5.1. Laser Atherectomy Device Market
    • 9.5.2. Mechanical Atherectomy Device Market
  • 9.6. Drivers and Limiters
    • 9.6.1. Market Drivers
    • 9.6.2. Market Limiters
  • 9.7. Competitive Market Share Analysis

Intravascular Lithotripsy Market

  • 10.1. Executive Summary
    • 10.1.1. Global Intravascular Lithotripsy Market Overview
    • 10.1.2. Competitive Analysis
    • 10.1.3. Procedures Included
    • 10.1.4. Regions Included
  • 10.2. Introduction
  • 10.3. Procedure Numbers
  • 10.4. Market Analysis and Forecast
  • 10.5. Drivers and Limiters
    • 10.5.1. Market Drivers
    • 10.5.2. Market Limiters
  • 10.6. Competitive Market Share Analysis

chronic total occlusion Device Market

  • 11.1. Executive Summary
    • 11.1.1. Global Chronic Total Occlusion Device Market Overview
    • 11.1.2. Competitive Analysis
    • 11.1.3. Procedures Included
    • 11.1.4. Markets Included
    • 11.1.5. Regions Included
  • 11.2. Introduction
  • 11.3. Procedure Numbers
    • 11.3.1. Total CTO Procedures
    • 11.3.2. Re-Entry Procedures
    • 11.3.3. Recanalization Procedures
  • 11.4. Market Overview
    • 11.4.1. By Segment
    • 11.4.2. By Region
  • 11.5. Market Analysis and Forecast
    • 11.5.1. Total Chronic Total Occlusion Device Market
    • 11.5.2. Re-Entry Device Market
    • 11.5.3. Recanalization Device Market
  • 11.6. Drivers and Limiters
    • 11.6.1. Market Drivers
    • 11.6.2. Market Limiters
  • 11.7. Competitive Market Share Analysis

surgical graft Market

  • 12.1. Executive Summary
    • 12.1.1. Global Surgical Graft Market Overview
    • 12.1.2. Competitive Analysis
    • 12.1.3. Procedures Included
    • 12.1.4. Markets Included
    • 12.1.5. Regions Included
  • 12.2. Introduction
  • 12.3. Procedure Numbers
    • 12.3.1. Total Surgical Graft Procedures
    • 12.3.2. Lower-Limb Surgical Graft Procedures
    • 12.3.3. Aorta Repair Surgical Graft Procedures
      • 12.3.3.1. AAA Surgical Graft Procedures
      • 12.3.3.2. TAA Surgical Graft Procedures
    • 12.3.4. Extra-Anatomical Bypass Surgical Graft Procedures
  • 12.4. Market Overview
    • 12.4.1. By Segment
    • 12.4.2. By Region
  • 12.5. Market Analysis and Forecast
    • 12.5.1. Total Surgical Graft Market
    • 12.5.2. Lower-Limb Surgical Graft Market
    • 12.5.3. Aorta Repair Surgical Graft Market
      • 12.5.3.1. AAA Surgical Graft Market
      • 12.5.3.2. TAA Surgical Graft Market
    • 12.5.4. Extra-Anatomical Bypass Surgical Graft Market
  • 12.6. Drivers and Limiters
    • 12.6.1. Market Drivers
    • 12.6.2. Market Limiters
  • 12.7. Competitive Market Share Analysis

stent graft Market

  • 13.1. Executive Summary
    • 13.1.1. Global Stent Graft Market Overview
    • 13.1.2. Competitive Analysis
    • 13.1.3. Procedures Included
    • 13.1.4. Markets Included
    • 13.1.5. Regions Included
  • 13.2. Introduction
  • 13.3. Procedure Numbers
    • 13.3.1. Total Stent Graft Procedures
    • 13.3.2. AAA Stent Graft Procedures
    • 13.3.3. Fenestrated Stent Graft Procedures
    • 13.3.4. TAA Stent Graft Procedures
  • 13.4. Market Overview
    • 13.4.1. By Segment
    • 13.4.2. By Region
  • 13.5. Market Analysis and Forecast
    • 13.5.1. Total Stent Graft Market
    • 13.5.2. AAA Stent Graft Market
    • 13.5.3. Fenestrated Stent Graft Market
    • 13.5.4. TAA Stent Graft Market
  • 13.6. Drivers and Limiters
    • 13.6.1. Market Drivers
    • 13.6.2. Market Limiters
  • 13.7. Competitive Market Share Analysis

embolic protection device Market

  • 14.1. Executive Summary
    • 14.1.1. Global Embolic Protection Device Market Overview
    • 14.1.2. Competitive Analysis
    • 14.1.3. Procedures Included
    • 14.1.4. Markets Included
    • 14.1.5. Regions Included
  • 14.2. Introduction
    • 14.2.1. Protection Mechanism
      • 14.2.1.1. Filter Basket
      • 14.2.1.2. Distal Balloon Occlusion
      • 14.2.1.3. Flow Redirection
  • 14.3. Procedure Numbers
  • 14.4. Market Overview
    • 14.4.1. By Segment
    • 14.4.2. By Region
  • 14.5. Market Analysis and Forecast
    • 14.5.1. Total Embolic Protection Device Market
    • 14.5.2. Carotid EPD Market
    • 14.5.3. Renal EPD Market
    • 14.5.4. Lower-Limb EPD Market
  • 14.6. Drivers and Limiters
    • 14.6.1. Market Drivers
    • 14.6.2. Market Limiters
  • 14.7. Competitive Market Share Analysis

Peripheral thrombus management Market

  • 15.1. Executive Summary
    • 15.1.1. Global Peripheral Thrombus Management Market Overview
    • 15.1.2. Competitive Analysis
    • 15.1.3. Procedures Included
    • 15.1.4. Markets Included
    • 15.1.5. Regions Included
  • 15.2. Introduction
  • 15.3. Procedure Numbers
  • 15.4. Market Overview
    • 15.4.1. By Segment
    • 15.4.2. By Region
  • 15.5. Market Analysis and Forecast
    • 15.5.1. Total Peripheral Thrombus Management Market
    • 15.5.2. Traditional Thrombectomy Device Market
    • 15.5.3. Pharmacomechanical Thrombectomy Device Market
  • 15.6. Drivers and Limiters
    • 15.6.1. Market Drivers
    • 15.6.2. Market Limiters
  • 15.7. Competitive Market Share Analysis

Inferior Vena Cava Filter Market

  • 16.1. Executive Summary
    • 16.1.1. Global Inferior Vena Cava Filter Market Overview
    • 16.1.2. Competitive Analysis
    • 16.1.3. Procedures Included
    • 16.1.4. Regions Included
  • 16.2. Introduction
  • 16.3. Procedure Numbers
  • 16.4. Market Analysis and Forecast
  • 16.5. Drivers and Limiters
    • 16.5.1. Market Drivers
    • 16.5.2. Market Limiters
  • 16.6. Competitive Market Share Analysis

Carotid Shunt Market

  • 17.1. Executive Summary
    • 17.1.1. Global Carotid Shunt Market Overview
    • 17.1.2. Competitive Analysis
    • 17.1.3. Procedures Included
    • 17.1.4. Regions Included
  • 17.2. Introduction
  • 17.3. Procedure Numbers
  • 17.4. Market Analysis and Forecast
  • 17.5. Drivers and Limiters
    • 17.5.1. Market Drivers
    • 17.5.2. Market Limiters
  • 17.6. Competitive Market Share Analysis

diagnostic & Interventional catheter Market

  • 18.1. Executive Summary
    • 18.1.1. Global Diagnostic & Interventional Catheter Market Overview
    • 18.1.2. Competitive Analysis
    • 18.1.3. Markets Included
    • 18.1.4. Regions Included
  • 18.2. Introduction
  • 18.3. Market Overview
    • 18.3.1. By Segment
    • 18.3.2. By Region
  • 18.4. Market Analysis and Forecast
    • 18.4.1. Total Diagnostic & Interventional Catheter Market
    • 18.4.2. Diagnostic Catheter Market
      • 18.4.2.1. Standard Diagnostic Catheter Market
      • 18.4.2.2. Hydrophilic Diagnostic Catheter Market
    • 18.4.3. Support Catheter Market
  • 18.5. Drivers and Limiters
    • 18.5.1. Market Drivers
    • 18.5.2. Market Limiters
  • 18.6. Competitive Market Share Analysis

Diagnostic & interventional guidewire Market

  • 19.1. Executive Summary
    • 19.1.1. Global Diagnostic & Interventional Guidewire Market Overview
    • 19.1.2. Competitive Analysis
    • 19.1.3. Markets Included
    • 19.1.4. Regions Included
  • 19.2. Introduction
  • 19.3. Market Overview
    • 19.3.1. By Segment
    • 19.3.2. By Region
  • 19.4. Market Analysis and Forecast
    • 19.4.1. Total Diagnostic & Interventional Guidewire Market
    • 19.4.2. Standard Guidewire Market
    • 19.4.3. Hydrophilic Guidewire Market
  • 19.5. Drivers and Limiters
    • 19.5.1. Market Drivers
    • 19.5.2. Market Limiters
  • 19.6. Competitive Market Share Analysis

Introducer Sheath Market

  • 20.1. Executive Summary
    • 20.1.1. Global Introducer Sheath Market Overview
    • 20.1.2. Competitive Analysis
    • 20.1.3. Regions Included
  • 20.2. Introduction
  • 20.3. Market Analysis and Forecast
  • 20.4. Drivers and Limiters
    • 20.4.1. Market Drivers
    • 20.4.2. Market Limiters
  • 20.5. Competitive Market Share Analysis

Vascular Closure Device Market

  • 21.1. Executive Summary
    • 21.1.1. Global Vascular Closure Device Market Overview
    • 21.1.2. Competitive Analysis
    • 21.1.3. Procedures Included
    • 21.1.4. Markets Included
    • 21.1.5. Regions Included
  • 21.2. Introduction
  • 21.3. Procedure Numbers
    • 21.3.1. Total Vascular Closure Device Procedures
    • 21.3.2. Invasive VCD Procedures
    • 21.3.3. Non-Invasive VCD Procedures
  • 21.4. Market Overview
    • 21.4.1. By Segment
    • 21.4.2. By Region
  • 21.5. Market Analysis and Forecast
    • 21.5.1. Total Vascular Closure Device Market
    • 21.5.2. Invasive VCD Market
      • 21.5.2.1. Small-Bore Invasive VCD Market
      • 21.5.2.2. Large-Bore Invasive VCD Market
    • 21.5.3. Non-Invasive VCD Market
  • 21.6. Drivers and Limiters
    • 21.6.1. Market Drivers
    • 21.6.2. Market Limiters
  • 21.7. Competitive Market Share Analysis

Transcatheter embolization Market

  • 22.1. Executive Summary
    • 22.1.1. Global Transcatheter Embolization Market Overview
    • 22.1.2. Competitive Analysis
    • 22.1.3. Procedures Included
    • 22.1.4. Markets Included
    • 22.1.5. Regions Included
  • 22.2. Introduction
    • 22.2.1. Particle Embolic Devices
  • 22.3. Procedure Numbers
    • 22.3.1. Total Transcatheter Embolization Procedures
    • 22.3.2. Particle Embolization Procedures
    • 22.3.3. Coil Embolization Procedures
  • 22.4. Market Overview
    • 22.4.1. By Segment
    • 22.4.2. By Region
  • 22.5. Market Analysis and Forecast
    • 22.5.1. Total Transcatheter Embolization Market
    • 22.5.2. Particle Embolization Market
      • 22.5.2.1. PVA Particle Market
      • 22.5.2.2. Microsphere Particle Market
      • 22.5.2.3. Drug-Eluting Particle Market
      • 22.5.2.4. Radioactive Particle Market
    • 22.5.3. Coil Embolization Market
  • 22.6. Drivers and Limiters
    • 22.6.1. Market Drivers
    • 22.6.2. Market Limiters
  • 22.7. Competitive Market Share Analysis

Peripheral Intravascular Ultrasound Market

  • 23.1. Executive Summary
    • 23.1.1. Global Peripheral Intravascular Ultrasound Market Overview
    • 23.1.2. Competitive Analysis
    • 23.1.3. Procedures Included
    • 23.1.4. Regions Included
  • 23.2. Introduction
  • 23.3. Procedure Numbers
  • 23.4. Market Analysis and Forecast
  • 23.5. Drivers and Limiters
    • 23.5.1. Market Drivers
    • 23.5.2. Market Limiters
  • 23.6. Competitive Market Share Analysis

Abbreviations